中国
大流行
可持续发展
公司治理
全球治理
政治学
2019年冠状病毒病(COVID-19)
业务
国际贸易
医学
财务
病理
法学
传染病(医学专业)
疾病
作者
Brice Tseen Fu Lee,Walker Darke,J. Schubert
出处
期刊:China Report
[SAGE]
日期:2024-11-01
卷期号:60 (4): 378-397
被引量:3
标识
DOI:10.1177/00094455241288047
摘要
This study explores China’s robust response to the Coronavirus Disease-2019 pandemic, employing health diplomacy and soft power strategies to boost international relations and global health outcomes. China’s contributions to international organisations, investments in biotechnology and provision of medical aid underline its pivotal role in health diplomacy. The country’s approach, encompassing the Health Silk Road and vaccine diplomacy, is viewed through the lens of soft power theory and health diplomacy theory. It is revealed that China’s initiatives, while offering valuable global health benefits, also strategically enhance its global influence and international relations. This article offers policy recommendations and underscores the importance of international cooperation, equitable access to health interventions, and the embrace of digital health technologies.
科研通智能强力驱动
Strongly Powered by AbleSci AI